13th Conference of Undiagnosed Diseases Network International / 5-7 September, 2024, Seoul, Korea / Seoul National University Children's Hospital, CJ Hall

Luncheon Symposium

Day 1 (November 20, Thu)

Luncheon Symposium 1 (Takeda Pharmaceuticals Korea Co.,Ltd)
Redefining CMV Management with Advanced Therapeutic Strategies
12:00-13:00ㅣRoom 4 (Emerald Hall A, 3F)
Novartis
Chair(s) Myoung Soo Kim (Severance Hospital, Korea)
Speakers(s) Why We Treat CMV: Evidence from KOTRY-CMV Study
Jaeseok Yang (Severance Hospital, Korea)
From Guidelines to Real-World Practice: Managing Difficult-to-Treat CMV
Hajeong Lee (Seoul National University Hospital, Korea)

Day 2 (November 21, Fri)

Luncheon Symposium 2 (Astellas Pharma Korea, Inc.)
Translating Drug Levels into Patient Outcomes in Tailored Immunosuppression
12:40-13:40ㅣRoom 1 (Convention Hall A+B+C, 4F)
astellas
Chair(s) Chan-Duck Kim (Kyungpook National University Hospital, Korea)
Jae Berm Park (Samsung Medical Center, Korea)
Speakers(s) From Clinical Indicators to Tailored Therapy: Optimizing Immunosuppression in KT
Jin Hyuk Paek (Keimyung University Dongsan Hospital, Korea)
From Drug Levels to Patient Outcomes: Practical Strategies for TAC Optimization
Hyun Jeong Kim (Severance Hospital, Korea)
Luncheon Symposium 3 (Chong Kun Dang Pharm.)
12:40-13:40ㅣRoom 4 (Emerald Hall A, 3F)
Chong Kun Dang Pharm.
Chair(s) Kyu Ha Huh (Severance Hospital, Korea)
Speakers(s) Small Dose, Big Impact: Clinical Utility of 0.25mg Tacrolimus Formulation in Managing Variability and Drug Interactions
Jun Bae Bang (Ajou University Hospital, Korea)

Day 3 (November 22, Sat)

Luncheon Symposium 4 (Novartis Korea)
Expanding the Horizon of Patient Care: From Cardiovascular to Transplantation
12:10-13:10ㅣRoom 4 (Emerald Hall A, 3F)
Novartis
Chair(s) Beom Seok Kim (Severance Hospital, Korea)
Speakers(s) Managing Severe/Complex Hypertension with a Novel Treatment, Entresto
Hae-Young Lee (Seoul National University Hospital, Korea)
Optimizing Long-Term Outcomes in Transplantation: The Evolving Role of Everolimus
Hye Eun Yoon (Seoul St. Mary’s Hospital, Catholic University of Korea, Korea)